Exelixis (EXEL) Fails to deliver data

Key failure to deliver metrics for Exelixis:

• Last SEC data release: 2024-12-31
• Last 15 days FTD volume: NZ$0.08 M
• Last 3 months FTD volume: NZ$3.07 M
• Last year FTD volume: NZ$3.07 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Exelixis (EXEL) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Exelixis (EXEL) - since 2013

Exelixis (EXEL) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
GlaxoSmithKline GSK	NZ$96.61 M	NZ$0.14 B	🇬🇧 UK
Sanofi SNY	NZ$4.14 M	NZ$72.79 M	🇫🇷 France
Merck MRK	NZ$76.67 M	NZ$0.12 B	🇺🇸 USA
Bristol-Myers Squibb BMY	NZ$0.19 B	NZ$0.47 B	🇺🇸 USA
Amgen AMGN	NZ$36.44 M	NZ$0.25 B	🇺🇸 USA
Johnson & Johnson JNJ	NZ$22.46 M	NZ$0.33 B	🇺🇸 USA
Pfizer PFE	NZ$37.96 M	NZ$0.35 B	🇺🇸 USA
Curis CRIS	NZ$0.19 M	NZ$0.87 M	🇺🇸 USA
AVEO Oncology AVEO	N/A	NZ$0.04 M	🇺🇸 USA